{"id":256025,"date":"2025-08-06T11:31:40","date_gmt":"2025-08-06T09:31:40","guid":{"rendered":"https:\/\/health.saypro.online\/index.php\/2025\/08\/06\/saypro-pediatric-asthma-management-protocols-3\/"},"modified":"2025-08-13T11:11:08","modified_gmt":"2025-08-13T09:11:08","slug":"saypro-pediatric-asthma-management-protocols-3","status":"publish","type":"post","link":"https:\/\/health.neftaly.net\/index.php\/2025\/08\/06\/saypro-pediatric-asthma-management-protocols-3\/","title":{"rendered":"Neftaly Pediatric Asthma Management Protocols"},"content":{"rendered":"\n

Neftaly Pediatric Asthma Management Protocols<\/strong><\/h1>\n\n\n\n

1. Introduction<\/strong><\/h2>\n\n\n\n

Asthma is one of the most common chronic conditions affecting children globally. Neftaly is committed to improving pediatric asthma outcomes through evidence-based, standardized, and culturally appropriate protocols that ensure early detection, appropriate treatment, and effective long-term management.<\/p>\n\n\n\n

These protocols are aligned with international guidelines such as GINA (Global Initiative for Asthma) and adapted for community-level implementation across diverse healthcare settings.<\/p>\n\n\n\n

\n\n\n\n

2. Goals of the Protocol<\/strong><\/h2>\n\n\n\n
    \n
  • Improve early identification and diagnosis of pediatric asthma<\/li>\n\n\n\n
  • Standardize treatment approaches based on severity and risk<\/li>\n\n\n\n
  • Enhance caregiver and patient education<\/li>\n\n\n\n
  • Promote adherence to controller medication and follow-up<\/li>\n\n\n\n
  • Reduce emergency visits and hospitalizations<\/li>\n\n\n\n
  • Enable safe and effective asthma care in both home and clinical settings<\/li>\n<\/ul>\n\n\n\n
    \n\n\n\n

    3. Definitions and Classifications<\/strong><\/h2>\n\n\n\n

    3.1 Definition of Asthma<\/strong><\/h3>\n\n\n\n

    A chronic inflammatory disease of the airways characterized by recurring symptoms, reversible airflow obstruction, and bronchospasm.<\/p>\n\n\n\n

    3.2 Asthma Severity Categories<\/strong><\/h3>\n\n\n\n
    Severity<\/th>Symptoms<\/th>Nighttime Awakenings<\/th>SABA Use<\/th>Activity Limitation<\/th>Lung Function<\/th><\/tr><\/thead>
    Intermittent<\/strong><\/td>\u22642 days\/week<\/td>\u22642x\/month<\/td>\u22642 days\/week<\/td>None<\/td>Normal FEV1<\/td><\/tr>
    Mild Persistent<\/strong><\/td>>2 days\/week<\/td>3\u20134x\/month<\/td>>2 days\/week<\/td>Minor limitation<\/td>FEV1 \u226580%<\/td><\/tr>
    Moderate Persistent<\/strong><\/td>Daily<\/td>>1x\/week<\/td>Daily<\/td>Some limitation<\/td>FEV1 60\u201380%<\/td><\/tr>
    Severe Persistent<\/strong><\/td>Throughout day<\/td>Frequent<\/td>Several times\/day<\/td>Extreme limitation<\/td>FEV1 <60%<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
    \n\n\n\n

    4. Diagnosis and Initial Assessment<\/strong><\/h2>\n\n\n\n
      \n
    • History:<\/strong> Recurrent wheezing, coughing, chest tightness, or shortness of breath, especially at night or with activity<\/li>\n\n\n\n
    • Physical Exam:<\/strong> Wheezing, prolonged expiration, accessory muscle use<\/li>\n\n\n\n
    • Risk Factors:<\/strong> Family history, allergies, environmental triggers (smoke, dust, pets)<\/li>\n\n\n\n
    • Diagnostic Tools:<\/strong>\n
        \n
      • Peak Expiratory Flow (PEF)<\/li>\n\n\n\n
      • Spirometry (children >5 years)<\/li>\n\n\n\n
      • Response to bronchodilators<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n
        \n\n\n\n

        5. Treatment Protocols<\/strong><\/h2>\n\n\n\n

        5.1 Acute Asthma Exacerbation Management<\/strong><\/h3>\n\n\n\n
        Severity<\/strong><\/th>Treatment<\/strong><\/th><\/tr><\/thead>
        Mild<\/td>Inhaled SABA (e.g., Salbutamol) 2\u20134 puffs every 20 min for up to 1 hour. Monitor.<\/td><\/tr>
        Moderate<\/td>SABA + Oral corticosteroids (Prednisolone 1\u20132 mg\/kg\/day, max 40 mg). Observe for response.<\/td><\/tr>
        Severe<\/td>SABA + Ipratropium bromide + Oral\/IV corticosteroids + O2 if saturation < 92%. Urgent referral if no response.<\/td><\/tr>
        Life-threatening<\/td>Emergency referral. Nebulized SABA every 20 min, high-flow oxygen, corticosteroids, and possible magnesium sulfate IV.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

        5.2 Long-Term Management (Stepwise Approach)<\/strong><\/h3>\n\n\n\n

        Step 1: Intermittent Asthma<\/strong><\/p>\n\n\n\n

          \n
        • SABA as needed<\/li>\n<\/ul>\n\n\n\n

          Step 2: Mild Persistent Asthma<\/strong><\/p>\n\n\n\n

            \n
          • Low-dose ICS + SABA as needed<\/li>\n<\/ul>\n\n\n\n

            Step 3: Moderate Persistent Asthma<\/strong><\/p>\n\n\n\n

              \n
            • Low-dose ICS + LABA
              OR<\/li>\n\n\n\n
            • Medium-dose ICS<\/li>\n<\/ul>\n\n\n\n

              Step 4: Severe Persistent Asthma<\/strong><\/p>\n\n\n\n

                \n
              • Medium\/high-dose ICS + LABA<\/li>\n\n\n\n
              • Consider leukotriene receptor antagonist (LTRA)<\/li>\n<\/ul>\n\n\n\n

                Step 5:<\/strong><\/p>\n\n\n\n

                  \n
                • Referral to specialist<\/li>\n\n\n\n
                • Consider biologics or additional systemic therapy<\/li>\n<\/ul>\n\n\n\n
                  \n\n\n\n

                  6. Asthma Action Plan<\/strong><\/h2>\n\n\n\n

                  Each child should have a written Asthma Action Plan<\/strong>, tailored to their severity and triggers. The plan includes:<\/p>\n\n\n\n

                    \n
                  • Daily management:<\/strong> medications and dosages<\/li>\n\n\n\n
                  • Green Zone:<\/strong> Stable \u2013 continue controller<\/li>\n\n\n\n
                  • Yellow Zone:<\/strong> Warning signs \u2013 increase reliever use, consider oral steroids<\/li>\n\n\n\n
                  • Red Zone:<\/strong> Emergency \u2013 seek immediate medical attention<\/li>\n<\/ul>\n\n\n\n
                    \n\n\n\n

                    7. Education and Caregiver Support<\/strong><\/h2>\n\n\n\n

                    Educate families and caregivers on:<\/p>\n\n\n\n

                      \n
                    • Inhaler technique (use of spacers)<\/li>\n\n\n\n
                    • Trigger identification and avoidance<\/li>\n\n\n\n
                    • Importance of medication adherence<\/li>\n\n\n\n
                    • Recognizing early signs of exacerbation<\/li>\n\n\n\n
                    • When to seek emergency care<\/li>\n<\/ul>\n\n\n\n
                      \n\n\n\n

                      8. Follow-Up and Monitoring<\/strong><\/h2>\n\n\n\n
                        \n
                      • Routine check-ups every 1\u20133 months for moderate to severe cases<\/li>\n\n\n\n
                      • Review control, inhaler technique, and adherence<\/li>\n\n\n\n
                      • Update asthma action plan as needed<\/li>\n\n\n\n
                      • Monitor growth and side effects from corticosteroids<\/li>\n<\/ul>\n\n\n\n
                        \n\n\n\n

                        9. Special Considerations<\/strong><\/h2>\n\n\n\n
                          \n
                        • School-based asthma care:<\/strong> Coordinate with teachers and school nurses<\/li>\n\n\n\n
                        • Comorbidities:<\/strong> Allergic rhinitis, eczema, obesity<\/li>\n\n\n\n
                        • Psychosocial impact:<\/strong> Address anxiety or stigma associated with chronic illness<\/li>\n<\/ul>\n\n\n\n
                          \n\n\n\n

                          10. Documentation and Reporting<\/strong><\/h2>\n\n\n\n

                          Healthcare providers should:<\/p>\n\n\n\n

                            \n
                          • Record all visits, medication changes, and exacerbations<\/li>\n\n\n\n
                          • Use standardized forms for asthma management<\/li>\n\n\n\n
                          • Report severe exacerbations or hospitalizations to Neftaly central registry for tracking outcomes<\/li>\n<\/ul>\n\n\n\n
                            \n\n\n\n

                            11. Training and Implementation<\/strong><\/h2>\n\n\n\n

                            Neftaly offers structured training for:<\/p>\n\n\n\n

                              \n
                            • Community Health Workers<\/li>\n\n\n\n
                            • Nurses and Clinic Staff<\/li>\n\n\n\n
                            • School Health Coordinators<\/li>\n<\/ul>\n\n\n\n

                              Training includes:<\/p>\n\n\n\n

                                \n
                              • Clinical management<\/li>\n\n\n\n
                              • Communication strategies<\/li>\n\n\n\n
                              • Emergency protocols<\/li>\n\n\n\n
                              • Simulation-based practice<\/li>\n<\/ul>\n\n\n\n
                                \n\n\n\n

                                12. Review and Updates<\/strong><\/h2>\n\n\n\n

                                These protocols are reviewed annually to ensure alignment with the latest clinical guidelines and local health policies. Feedback from frontline workers and caregivers is integrated into each revision.<\/p>\n\n\n\n

                                \n\n\n\n

                                For questions, feedback, or support on implementation, please contact the Neftaly Health Programs Office.<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

                                Neftaly Pediatric Asthma Management Protocols 1. Introduction Asthma is one of the most common chronic conditions affecting children globally. Neftaly is committed to improving pediatric asthma outcomes through evidence-based, standardized, and culturally appropriate protocols that ensure early detection, appropriate treatment, and effective long-term management. These protocols are aligned with international guidelines such as GINA (Global […]<\/p>\n","protected":false},"author":20,"featured_media":391881,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[4244,171,4,4289,282],"class_list":["post-256025","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saypro-health-insights","tag-asthma","tag-management","tag-saypro","tag-pediatric","tag-protocols-2"],"_links":{"self":[{"href":"https:\/\/health.neftaly.net\/index.php\/wp-json\/wp\/v2\/posts\/256025","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/health.neftaly.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/health.neftaly.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/health.neftaly.net\/index.php\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/health.neftaly.net\/index.php\/wp-json\/wp\/v2\/comments?post=256025"}],"version-history":[{"count":0,"href":"https:\/\/health.neftaly.net\/index.php\/wp-json\/wp\/v2\/posts\/256025\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/health.neftaly.net\/index.php\/wp-json\/wp\/v2\/media\/391881"}],"wp:attachment":[{"href":"https:\/\/health.neftaly.net\/index.php\/wp-json\/wp\/v2\/media?parent=256025"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/health.neftaly.net\/index.php\/wp-json\/wp\/v2\/categories?post=256025"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/health.neftaly.net\/index.php\/wp-json\/wp\/v2\/tags?post=256025"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}